Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Candesartan cilexetil
Strength: 8 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Apr 1998
Registration: 61893
Marketing authorisation holder: Cheplapharm Arzneimittel Gmbh
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

ATACAND 4 mg COMPRIMIDOSCandesartan cilexetil · 4 mg · comprimidoSpain

BLOPRESS 16 mg COMPRIMIDOSCandesartan cilexetil · 16,000 mg · comprimidoSpain

BLOPRESS 32 mg COMPRIMIDOSCandesartan cilexetil · 32 mg · comprimidoSpain

BLOPRESS 4 mg COMPRIMIDOSCandesartan cilexetil · 4,000 mg · comprimidoSpain

BLOPRESS 8 mg COMPRIMIDOSCandesartan cilexetil · 8,000 mg · comprimidoSpain

CANDESARTAN ALMUS 16 mg COMPRIMIDOS EFGCandesartan cilexetil · 16 mg · comprimidoSpain

CANDESARTAN ALMUS 32 mg COMPRIMIDOS EFGCandesartan cilexetil · 32 mg · comprimidoSpain

CANDESARTAN ALMUS 8 mg COMPRIMIDOS EFGCandesartan cilexetil · 8 mg · comprimidoSpain

CANDESARTAN ALTER 16 mg COMPRIMIDOS EFGCandesartan cilexetil · 16 mg · comprimidoSpain

CANDESARTAN ALTER 32 mg COMPRIMIDOS EFGCandesartan cilexetil · 32 mg · comprimidoSpain